Stay updated on Ixazomib Combo in Relapsed/Refractory MM Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T22:34:05.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T15:24:41.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:41:46.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The status has changed from 'Recruiting' to 'Active, not recruiting' as of January 22, 2025.
    Difference
    2%
    Check dated 2025-01-27T04:46:01.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T02:03:05.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T22:42:44.000Z thumbnail image

Stay in the know with updates to Ixazomib Combo in Relapsed/Refractory MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.